4000 Tests Completed in July - Third Full Month of Operations
VANCOUVER, BC / ACCESSWIRE / August 5, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ('Empower' or the 'Company') an integrated healthcare company - serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory - announced today its COVID-19 testing solutions offered in and around Vancouver's Port of Vancouver and Canada Place processed more than 4000 tests for the month of July. The Company also has more than 600 appointments confirmed for the remainder of the cruise season.
'More than half way into this year's cruise season, we're proud to have the cruise industry standing behind our fully accredited COVID-19 testing solutions in Vancouver,' stated Steven McAuley, Chairman and CEO of Empower Clinics. 'I'm grateful and proud of our entire team who continually deliver excellent, reliable and convenient testing solutions. The feedback from cruise line companies and their passengers has been very positive throughout the season. We remain ready to serve for the rest of the season and anticipate continued strong volumes for August and September.'
While the cruise season in Vancouver runs until November, the peak season runs from July to October based on cruise schedules managed by the Port of Vancouver. With several ships carrying more than 4000 people, the Vancouver Fraser Port Authority expects more than 300 cruise ship calls for the 2022 season - nearly an 8% increase from 288 calls in pre-pandemic 2019.
All of Empower's COVID-19 testing solutions are fully accredited by the College of Physicians and Surgeons of British Columbia's Diagnostic Accreditation Program (DAP). All COVID-19 testing in British Columbia requires accreditation by the College's Diagnostic Accreditation Program (DAP). Empower's fully accredited COVID-19 testing solutions includes three certified sites at the Port of Vancouver, Canada Place and Fairmont Waterfront Hotel as well as a recently accredited concierge mobile service.
Passengers can visit https://www.empowerclinics.com/covid-19-testing/ to book COVID-19 testing solutions that include virtual (telehealth) or in-person Rapid Antigen / Rapid PCR (RT-Lamp) testing at a site at Fairmont Waterfront Hotel - adjacent to the port terminal at Canada Place.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
Steven McAuley CEO
Business Development & Communications
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain 'forward-looking statements' or 'forward-looking information' (collectively 'forward looking statements') within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as 'plans', 'continues', 'expects', 'projects', 'intends', 'believes', 'anticipates', 'estimates', 'may', 'will', 'potential', 'proposed' and other similar words, or information that certain events or conditions 'may' or 'will' occur. Forward-looking statements in this news release include statements regarding: that volumes will remain strong for the rest of the season. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com: